Literature DB >> 9237660

Inhibitors of phosphoprotein phosphatases 1 and 2A cause activation of a 53 kDa protein kinase accompanying the apoptotic response of breast cancer cells.

G P Rossini1, C Pinna, R Viviani.   

Abstract

Treatment of MCF-7 breast cancer cells with 50 nM okadaic acid triggers an apoptotic response which is accompanied by a 7-fold increase in the activity of a protein kinase with a relative molecular mass of 53 kDa. The activity of the kinase was stimulated by cell treatment with inhibitors of phosphoprotein phosphatase 1 and 2A, but not by stressing conditions. Okadaic acid-induced stimulation of the 53 kDa protein kinase was not abolished by coincubation of cells with cycloheximide. We conclude that stimulation of the 53 kDa protein kinase by inhibitors of phosphoprotein phosphatases involves pre-existing molecular components whose activity depends on the phosphorylation state of serine/threonine residues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237660     DOI: 10.1016/s0014-5793(97)00659-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Algal biotoxins of marine origin: new indications from the European Union.

Authors:  R Poletti; A Milandri; M Pompei
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Okadaic acid, an apoptogenic toxin for symbiotic/parasitic annelids in the demosponge Suberites domuncula.

Authors:  Heinz C Schröder; Hans J Breter; Ernesto Fattorusso; Hiroshi Ushijima; Matthias Wiens; Renate Steffen; Renato Batel; Werner E G Müller
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

3.  Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.

Authors:  E Rundén; P O Seglen; F M Haug; O P Ottersen; T Wieloch; M Shamloo; J H Laake
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.